Eton Pharmaceuticals (ETON) Other Non Operating Income (2021 - 2024)

Eton Pharmaceuticals has disclosed Other Non Operating Income across 4 years of filings, most recently posting $1.2 million for Q4 2024.

• In Q4 2024, Other Non Operating Income rose 238.39% year-over-year to $1.2 million; the TTM figure through Dec 2024 stood at $1.2 million (up 3809.68% YoY), while the FY2025 annual figure was $63000.0, down 94.52% from the prior year.
• Other Non Operating Income came in at $1.2 million for Q4 2024 at Eton Pharmaceuticals, up from -$831000.0 in the prior quarter.
• In the past five years, Other Non Operating Income ranged from a high of $1.2 million in Q4 2024 to a low of -$831000.0 in Q4 2023.
• Average Other Non Operating Income over 4 years is $459200.0, with a median of $800000.0 recorded in 2023.
• Year-over-year, Other Non Operating Income tumbled 202.34% in 2023 and surged 238.39% in 2024.
• Over 4 years, Other Non Operating Income stood at $365000.0 in 2021, then soared by 122.47% to $812000.0 in 2022, then plunged by 202.34% to -$831000.0 in 2023, then surged by 238.39% to $1.2 million in 2024.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $1.2 million in Q4 2024, -$831000.0 in Q4 2023, and $800000.0 in Q2 2023.